Stay updated on Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The clinical trial record is displayed with its study design, treatment arms, eligibility criteria, outcome measures, and record dates, including that the study is completed and results are posted.
    Difference
    51%
    Check dated 2026-11-10T14:50:34.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T15:52:03.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    A site-wide NIH notice about transitioning terminology from “Artificial Intelligence” to “Super Intelligence” appears, and the footer revision advances from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T15:32:57.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The displayed site revision in the footer advances from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-13T15:29:20.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, preventing access to the study record and its associated documents. This change hides the study details that were previously visible on the page.
    Difference
    19%
    Check dated 2026-09-22T21:51:57.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.7.0, signaling an update to the page. The study content and displayed information remain unchanged.
    Difference
    0.1%
    Check dated 2026-09-15T21:36:31.000Z thumbnail image

Stay in the know with updates to Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page.